Search - tctmd.com

Displaying 181 - 200 of 270

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Caitlin E. Cox

June 05, 2019

News Conference News SCAI 2019

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Yael L. Maxwell

May 31, 2019

News Daily News

FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting

Todd Neale

May 21, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

Presentation

IMPELLA vs Intra-Aortic Balloon PumpA Reflective Perspective

Presenter: David Cox

April 11, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

News Conference News ACC 2019

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

Caitlin E. Cox

March 16, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

FDA Warns Healthcare Providers of Potential Rise in Death Rate With Impella RP

Caitlin E. Cox

February 04, 2019

News Daily News

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

Michael O'Riordan

January 21, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

Shelley Wood

December 31, 2018

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Caitlin E. Cox

December 11, 2018

News Conference News AHA 2018

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

Caitlin E. Cox

November 11, 2018

News Conference News AHA 2018

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

Todd Neale

November 11, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

Presentation TCT Abstracts Posters 2018

Complete Revascularization of Complex Multi-vessel Disease with Hybrid Total Endoscopic Bypass and Impella-assisted Percutaneous Coronary Intervention of Chronic Total Occlusion

Presenter: Taishi Hirai

September 25, 2018

Advertisement

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

IMPELLA vs Intra-Aortic Balloon PumpA Reflective Perspective

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

TCTMD’s Top 10 Most Popular Stories for February 2019

FDA Warns Healthcare Providers of Potential Rise in Death Rate With Impella RP

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

TCTMD’s Top 10 Most Popular Stories for December 2018

The Biggest News of 2018: TCTMD’s Top 10

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Complete Revascularization of Complex Multi-vessel Disease with Hybrid Total Endoscopic Bypass and Impella-assisted Percutaneous Coronary Intervention of Chronic Total Occlusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content